4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-042841
Options or other derivatives
- President and CEO acquired 1,017,500 shares (grant or award)
- President and CEO returned 1,017,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chacko Jacob President and CEO | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −437,500 | 0 | D | ||
| Chacko Jacob President and CEO | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −280,000 | 0 | D | ||
| Chacko Jacob President and CEO | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −300,000 | 0 | D | ||
| Chacko Jacob President and CEO | 2022-07-20 | Grant or award · Stock Option (right to buy) | +437,500 | 437,500 | D | ||
| Chacko Jacob President and CEO | 2022-07-20 | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | D | ||
| Chacko Jacob President and CEO | 2022-07-20 | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | D | ||
Loading xslF345X03/doc4.xml…